ABCL ABCELLERA BIOLOGICS INC
FollowStock (common), issuer CIK 1703057
Filings received so far for Q3 2026: 4 13F filers report a position in ABCL shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Green Alpha Advisors, LLC | 22,930 | $335K | 0.23% | +1,014 | 13F-HRTimeline |
| DKM Wealth Management, Inc. | 10,000 | $146K | 0.09% | 0 | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 3,283 | $47.9K | <0.01% | -3,362 | 13F-HRTimeline |
| Pacifica Partners Inc. | 2,230 | $31K | 0.01% | 0 | 13F-HRTimeline |